Conference symposium

Our CEO & founder, Dr Ross Upton, PhD, introduces our AI diagnostic for HFpEF detection at the FNIH AMP Symposium, sharing findings on its performance in clinical practice.

Ultromics is partnered with Foundation for the National Institutes of Health on The Accelerating Medicines Partnership® Heart Failure Program (AMP® HF). This initiative brings together partners from the public, private, and nonprofit sectors to investigate heart failure with preserved ejection fraction (HFpEF), addressing a significant unmet need in cardiovascular health that continues to challenge researchers and clinicians.

We are proud to partner with them, utilizing Ultromics' cutting-edge technology to enhance HFpEF detection and facilitate increased patient access to effective therapies.